Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 3012 (114th)

Right to Try Act of 2015

referredUnited States· United States Congress· EN

Introduced

9 July 2015

Last action

29 July 2015 · Referred

Status

Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.

Sponsors

Rep. Salmon, Matt [R-AZ-5], Rep. Stutzman, Marlin A. [R-IN-3], Rep. Gosar, Paul A. [R-AZ-9], Rep. Blumenauer, Earl [D-OR-3], Sen. Cramer, Kevin [R-ND], Rep. Franks, Trent [R-AZ-8], Rep. Messer, Luke [R-IN-6], Rep. Olson, Pete [R-TX-22], Rep. Schweikert, David [R-AZ-1], Rep. Palmer, Gary J. [R-AL-6], Rep. Grothman, Glenn [R-WI-6], Rep. King, Steve [R-IA-4], Sen. Young, Todd [R-IN], Rep. Fitzpatrick, Michael G. [R-PA-8], Rep. Gohmert, Louie [R-TX-1], Rep. Westerman, Bruce [R-AR-4], Rep. Brat, Dave [R-VA-7], Rep. Lamborn, Doug [R-CO-5], Rep. Boustany, Charles W., Jr. [R-LA-3], Sen. McSally, Martha [R-AZ], Rep. Stewart, Chris [R-UT-2], Rep. McClintock, Tom [R-CA-5], Rep. Cicilline, David N. [D-RI-1], Rep. Rohrabacher, Dana [R-CA-48], Rep. Sensenbrenner, F. James, Jr. [R-WI-5], Rep. Graves, Tom [R-GA-14], Rep. Love, Mia B. [R-UT-4], Rep. Bishop, Mike [R-MI-8], Rep. Lance, Leonard [R-NJ-7], Rep. Cohen, Steve [D-TN-9], Rep. Mulvaney, Mick [R-SC-5], Rep. Rouzer, David [R-NC-7], Rep. Roby, Martha [R-AL-2], Rep. Allen, Rick W. [R-GA-12], Rep. Hice, Jody B. [R-GA-10], Rep. LaMalfa, Doug [R-CA-1], Rep. Walker, Mark [R-NC-6], Rep. Barton, Joe [R-TX-6], Rep. Roe, David P. [R-TN-1], Rep. Sanford, Mark [R-SC-1], Rep. Yoho, Ted S. [R-FL-3], Rep. Meadows, Mark [R-NC-11], Rep. Peterson, Collin C. [D-MN-7], Rep. Coffman, Mike [R-CO-6], Rep. Rokita, Todd [R-IN-4], Rep. Hill, J. French [R-AR-2], Rep. Pittenger, Robert [R-NC-9], Sen. Lummis, Cynthia M. [R-WY]

Subjects

Healthcare

Source updated

12 August 2025

Healthcare

Summary

Right to Try Act of 2015 Bars the federal government from prohibiting or restricting the production, manufacture, distribution, prescribing, dispensing, possession, or use of an experimental drug, biological product, or device that is: (1) intended to treat a patient who has been diagnosed with a terminal illness; and (2) authorized by, and in accordance with, state law. Defines an "experimental drug, biological product, or device" as one that: (1) has successfully completed a phase 1 clinical investigation; (2) remains under investigation in a clinical trial approved by the Food and Drug Administration; and (3) is not approved, licensed, or cleared for commercial distribution under the Federal Food, Drug, or Cosmetic Act or the Public Health Service Act.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 9 July 2015

    Introduced

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Source: IntroReferral

  2. 9 July 2015

    Introduced

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Source: IntroReferral

  3. 9 July 2015

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 9 July 2015

    Introduced

    Introduced in House

    Source: IntroReferral

  5. 10 July 2015

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

  6. 29 July 2015

    Referred

    Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 9 July 2015

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 9 July 2015

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 9 July 2015

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Showing 48 of 64 sponsors and actors.

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.